Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Krishna Nalleballe

Concepts (151)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
14
2022
492
2.620
Why?
Thrombolytic Therapy
4
2022
110
1.300
Why?
Pneumonia, Viral
6
2020
168
1.290
Why?
Fibrinolytic Agents
4
2022
124
1.290
Why?
Coronavirus Infections
6
2020
177
1.270
Why?
Tissue Plasminogen Activator
3
2020
109
1.250
Why?
Endovascular Procedures
2
2022
173
0.840
Why?
Pandemics
8
2020
559
0.840
Why?
Cavernous Sinus
1
2022
15
0.800
Why?
Carotid-Cavernous Sinus Fistula
1
2022
11
0.800
Why?
Conflict of Interest
2
2020
25
0.740
Why?
Embolization, Therapeutic
1
2022
88
0.740
Why?
Iodine Compounds
1
2020
7
0.720
Why?
Brain Edema
1
2020
41
0.700
Why?
Brain Ischemia
4
2022
161
0.650
Why?
Mucopolysaccharidosis II
1
2018
1
0.650
Why?
Contrast Media
1
2020
184
0.640
Why?
Cardiology
1
2020
89
0.640
Why?
Medicare
1
2020
246
0.640
Why?
Coronary Angiography
1
2020
334
0.630
Why?
Physicians
1
2020
233
0.570
Why?
Hospitalization
6
2022
652
0.500
Why?
Databases, Factual
3
2020
658
0.430
Why?
Telemedicine
1
2019
448
0.420
Why?
Humans
29
2022
49974
0.420
Why?
Headache
2
2022
76
0.370
Why?
Aged
10
2021
9310
0.370
Why?
Time Factors
4
2020
2903
0.360
Why?
Autoimmune Diseases
2
2020
101
0.340
Why?
Ischemic Attack, Transient
2
2020
56
0.340
Why?
Immunosuppressive Agents
2
2020
221
0.330
Why?
United States
6
2020
4860
0.310
Why?
Female
16
2021
26472
0.290
Why?
Male
14
2021
25241
0.270
Why?
Arkansas
4
2019
1977
0.270
Why?
Middle Aged
11
2021
12069
0.260
Why?
Emergency Service, Hospital
2
2020
486
0.260
Why?
Tomography, X-Ray Computed
2
2020
1159
0.230
Why?
Triage
2
2021
62
0.230
Why?
Thrombectomy
2
2020
67
0.220
Why?
Drug Industry
2
2020
38
0.220
Why?
Neuroimaging
2
2020
84
0.220
Why?
Critical Care
2
2021
213
0.200
Why?
Retrospective Studies
5
2020
6108
0.200
Why?
Sinus Thrombosis, Intracranial
1
2021
17
0.190
Why?
Myasthenia Gravis
1
2021
17
0.190
Why?
Hospitalists
1
2020
11
0.190
Why?
Intracranial Thrombosis
1
2020
16
0.190
Why?
Ageusia
1
2020
6
0.180
Why?
Olfaction Disorders
1
2020
7
0.180
Why?
Neuromuscular Diseases
1
2020
30
0.180
Why?
Osmolar Concentration
1
2020
62
0.180
Why?
Health Services Misuse
1
2020
13
0.180
Why?
Lymphoma, Non-Hodgkin
1
2020
60
0.180
Why?
Multiple Sclerosis
1
2020
66
0.180
Why?
Health Care Sector
1
2020
15
0.180
Why?
Time-to-Treatment
1
2020
61
0.180
Why?
Neurologic Examination
1
2020
77
0.180
Why?
Infarction, Middle Cerebral Artery
1
2020
40
0.180
Why?
Mood Disorders
1
2020
59
0.180
Why?
Young Adult
2
2020
3958
0.170
Why?
Patient Transfer
1
2020
94
0.170
Why?
Brain Diseases
1
2020
82
0.170
Why?
Venous Thrombosis
1
2020
90
0.170
Why?
Subarachnoid Hemorrhage
1
2020
65
0.170
Why?
Drug-Eluting Stents
1
2020
93
0.170
Why?
Suicidal Ideation
1
2020
96
0.170
Why?
Fabry Disease
1
2019
9
0.170
Why?
Enzyme Replacement Therapy
1
2019
17
0.170
Why?
Recombinant Fusion Proteins
1
2010
181
0.170
Why?
Fluorocarbons
1
2019
45
0.170
Why?
Hospitals
1
2020
175
0.170
Why?
Nervous System Diseases
1
2020
88
0.160
Why?
Tomography Scanners, X-Ray Computed
1
2018
12
0.160
Why?
Aged, 80 and over
3
2020
3129
0.160
Why?
Angiogenesis Inhibitors
1
2010
187
0.160
Why?
Angiography, Digital Subtraction
1
2018
27
0.160
Why?
Neuroprotective Agents
1
2019
105
0.160
Why?
Seizures
1
2020
195
0.160
Why?
Anxiety
1
2020
274
0.150
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
130
0.150
Why?
Pain
1
2020
379
0.150
Why?
Meningitis
1
2016
24
0.140
Why?
Referral and Consultation
1
2019
285
0.140
Why?
Diagnosis, Differential
1
2020
1037
0.140
Why?
Myocardial Infarction
1
2020
389
0.140
Why?
Antibodies, Monoclonal
1
2010
459
0.130
Why?
Percutaneous Coronary Intervention
1
2020
297
0.130
Why?
Ovarian Neoplasms
1
2010
447
0.130
Why?
Plasma Cells
1
2016
223
0.130
Why?
Magnetic Resonance Imaging
2
2020
1537
0.120
Why?
Adult
5
2020
13236
0.120
Why?
RNA-Directed DNA Polymerase
1
2002
6
0.110
Why?
Oligodeoxyribonucleotides
1
2002
29
0.110
Why?
DNA, Complementary
1
2002
135
0.100
Why?
Adolescent
2
2020
6356
0.100
Why?
Antineoplastic Agents
1
2010
1171
0.100
Why?
Mycobacterium tuberculosis
1
2002
285
0.090
Why?
Treatment Outcome
4
2022
5141
0.090
Why?
Intubation, Intratracheal
2
2021
118
0.080
Why?
Cohort Studies
2
2022
1422
0.070
Why?
Prevalence
2
2020
944
0.070
Why?
Risk Factors
2
2022
3613
0.050
Why?
Intracranial Hemorrhages
1
2022
38
0.050
Why?
Multiple Myeloma
1
2016
2929
0.050
Why?
Cerebral Hemorrhage
1
2022
104
0.050
Why?
Cranial Sinuses
1
2021
10
0.050
Why?
Industry
1
2020
17
0.050
Why?
Arthritis, Psoriatic
1
2020
9
0.050
Why?
Spondylitis, Ankylosing
1
2020
9
0.050
Why?
Cranial Nerves
1
2020
14
0.050
Why?
Disease Susceptibility
1
2021
89
0.050
Why?
Endocrine System Diseases
1
2010
10
0.040
Why?
Colitis, Ulcerative
1
2020
50
0.040
Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
22
0.040
Why?
Mortality
1
2020
99
0.040
Why?
Arthritis, Rheumatoid
1
2020
105
0.040
Why?
Registries
1
2022
522
0.040
Why?
Maximum Tolerated Dose
1
2019
37
0.040
Why?
Crohn Disease
1
2020
90
0.040
Why?
Tertiary Care Centers
1
2019
77
0.040
Why?
Administration, Oral
1
2020
426
0.040
Why?
alpha-Galactosidase
1
2019
9
0.040
Why?
Disease Outbreaks
1
2020
125
0.040
Why?
Administration, Intravenous
1
2019
69
0.040
Why?
Disability Evaluation
1
2019
87
0.040
Why?
Hemorrhage
1
2020
197
0.040
Why?
Skin Diseases
1
2010
112
0.040
Why?
Gastrointestinal Diseases
1
2010
126
0.040
Why?
Electronic Health Records
1
2021
209
0.040
Why?
Drug Administration Schedule
1
2019
376
0.040
Why?
Recovery of Function
1
2019
188
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2010
225
0.040
Why?
Comorbidity
1
2019
615
0.040
Why?
Patient Readmission
1
2019
219
0.040
Why?
Double-Blind Method
1
2019
681
0.040
Why?
Prognosis
1
2022
1942
0.040
Why?
Fatal Outcome
1
2016
195
0.030
Why?
Follow-Up Studies
1
2020
2182
0.030
Why?
Risk Assessment
1
2019
1259
0.030
Why?
Cardiovascular Diseases
1
2010
440
0.030
Why?
Prospective Studies
1
2020
2364
0.030
Why?
Cross-Sectional Studies
1
2019
1557
0.030
Why?
DNA Primers
1
2002
207
0.030
Why?
Infant
1
2020
3567
0.030
Why?
Child, Preschool
1
2020
3871
0.020
Why?
Transcription, Genetic
1
2002
369
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2002
411
0.020
Why?
Gene Expression Regulation, Bacterial
1
2002
191
0.020
Why?
RNA, Messenger
1
2002
1105
0.020
Why?
Child
1
2020
6847
0.020
Why?
Nalleballe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description